When you ask how SaiyanMed tests every batch for quality assurance, the answer is straightforward: they run every single batch through an independent third-party lab, specifically Janoshik Analytical, and publish the raw, verifiable certificates of analysis (CoAs) for each batch. This isn't a spot-check or a random sample from a larger production run. It's a 100% batch-level testing protocol. For every lot of peptide raw material that goes through their lyophilization process, a representative sample is pulled, sealed, and shipped to Janoshik. The lab then performs high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to determine purity, identity, and molecular weight. The results are then posted on the saiyanmed website with a unique batch number, so you can cross-reference the report directly with the lab's own database. This eliminates the common industry practice of reusing a single CoA for multiple batches or hiding behind vague "lab reports" that don't link back to a specific lot.
The testing protocol is rooted in the company's material science background. The founder, Eric, holds a Bachelor's degree in Materials Science from a leading Chinese university, specializing in biomaterials. That academic foundation directly translates into a process that treats peptide raw materials as engineering inputs, not commodities. Before any raw material even enters the production line, it undergoes a pre-qualification step. The raw material supplier must provide their own CoA, but SaiyanMed doesn't take that at face value. They perform an in-house verification using a calibrated HPLC system to check for gross impurities or incorrect peptide content. Only after that internal gate passes does the material move to the lyophilization stage. After lyophilization, the final product is sampled again, and that sample is sent to Janoshik for the definitive test. The entire cycle, from raw material receipt to final CoA publication, typically takes 7 to 10 business days, depending on the lab's turnaround time.
The data from these tests is not just a number on a PDF. It's granular. A typical Janoshik CoA for a SaiyanMed batch will show the purity percentage to two decimal places, the exact retention time from the HPLC run, the mass spectrum scan showing the main peak and any fragment ions, and a detailed list of any detected impurities, often with their own retention times and relative percentages. For example, a recent batch of their BPC-157 showed a purity of 99.32% with a single impurity peak at 0.68% that was identified as a truncated peptide fragment. That level of detail is rare in the research peptide space, where most suppliers only provide a single purity number. The table below shows a typical breakdown of what you'd see on a Janoshik CoA for a SaiyanMed product:
Parameter | Value | Method
Purity (HPLC) | 99.32% | Reverse-Phase HPLC at 220 nm
Impurity 1 | 0.68% | Retention time 8.21 min, identified as truncated fragment
Molecular Weight (MS) | 1419.6 Da | ESI-MS, positive ion mode
Theoretical MW | 1419.5 Da | N/A
Mass Error | +0.1 Da | Within acceptable tolerance (< 1 Da)
Appearance | White lyophilized powder | Visual inspection
Solubility | Clear, colorless solution at 1 mg/mL in water | Visual inspection after reconstitution
This level of testing is not cheap. Each Janoshik analysis costs between $150 and $300 per sample, depending on the complexity of the peptide and the number of tests requested. For a company that tests every batch, that adds up quickly. But it's a direct reflection of their stated mission: to provide trustworthy research-grade peptides. The alternative, which is common in the industry, is to buy a bulk CoA from the raw material supplier and reuse it for all subsequent batches. That practice is essentially worthless because it doesn't account for degradation during shipping, storage, or the lyophilization process itself. SaiyanMed's approach is more expensive, but it's the only way to guarantee that the product you receive matches the specification.
The company's infrastructure supports this testing rigor. They operate a US-based warehouse, which means that domestic researchers get their materials fast, usually within 2 to 4 business days. But more importantly, the warehouse environment is controlled. Temperature and humidity are logged continuously, and the storage area is maintained at a consistent 20-22°C with low humidity, which is critical for preserving the stability of lyophilized peptides. The raw materials are stored in sealed, desiccated containers before processing. The lyophilization equipment itself is a modern, pharmaceutical-grade freeze-dryer that can handle multiple batches per day. The process parameters—shelf temperature, vacuum pressure, and cycle time—are documented for each batch and are part of the batch record that accompanies the sample to Janoshik. This means that if a batch fails purity testing, the production team can trace back to the exact cycle parameters and raw material lot to identify the root cause.
Another layer of quality assurance is the company's legal and compliance structure. SaiyanMed is a registered Hong Kong entity with a commercial registry number (78941092) and an official location in Kwai Chung. This isn't a fly-by-night operation. Having a registered legal entity means that there is a paper trail for every transaction, and the company is subject to Hong Kong's business regulations. The communications desk is reachable at [email protected], and they actually respond to technical questions about the CoAs. If you email them asking about a specific batch number, you'll get a reply with the link to the Janoshik report and a brief explanation of the results. That level of customer support is rare in the peptide industry, where most suppliers operate through encrypted messaging apps and disappear after the sale.
The testing protocol also extends to the raw material selection process. SaiyanMed sources its raw materials from a small number of pre-qualified suppliers, primarily in China, where the majority of peptide raw materials are manufactured. But they don't just buy from the cheapest supplier. They evaluate suppliers based on their own manufacturing standards, including their cGMP compliance, their own in-house testing capabilities, and their track record of delivering consistent quality. The raw material suppliers are audited periodically, and any supplier that fails to meet the purity or consistency standards is dropped. This is a significant operational cost, but it's necessary to maintain the batch-to-batch consistency that researchers need. The company's founder, Eric, has stated that he personally reviews every raw material CoA before it's accepted into inventory.
In practice, this means that a researcher ordering a vial of, say, 5 mg of Semax from SaiyanMed will receive a product that has been tested at three points: the raw material supplier's own test, SaiyanMed's in-house verification, and the final Janoshik test. The CoA for that specific batch will be available on the product page, and it will include the HPLC chromatogram, the mass spectrum, and the purity calculation. The researcher can then take that CoA and compare it to the product they received. If the product looks different—if it's discolored, if it doesn't dissolve properly, or if the vial is damaged—they can contact support and get a replacement or a refund. That's a warranty that most suppliers don't offer because they can't back it up with data.
The company's commitment to testing is also reflected in their product portfolio. They don't sell every peptide under the sun. They focus on a curated list of research-grade compounds, including BPC-157, TB-500, Semax, Selank, Epitalon, and a few others. Each of these compounds has a well-documented research profile, and the company's research team continuously refines the lyophilization processes to improve stability and solubility. For example, they've optimized the freeze-drying cycle for BPC-157 to minimize the formation of the cyclic dimer, which is a common impurity. That optimization is based on internal data from their own HPLC runs and feedback from Janoshik's testing. It's a continuous improvement loop that directly benefits the end user.
The logistics framework also plays a role in quality assurance. Orders are routed automatically based on the customer's location. For US customers, the order is fulfilled from the US warehouse, which reduces shipping time and minimizes the risk of temperature excursions during transit. For international orders, the company uses temperature-controlled packaging and expedited shipping to ensure that the product arrives in good condition. The packaging itself is designed to protect the lyophilized powder from moisture and light, with a sealed mylar bag and a desiccant pack. The vials are individually packed in foam inserts to prevent breakage. Every shipment includes a printed copy of the CoA for that batch, so the researcher has immediate access to the test results without having to go online.
One of the most common questions researchers ask is: "How do I know the CoA is real?" SaiyanMed addresses this by using Janoshik, which is a well-known and respected lab in the peptide community. Janoshik publishes their own database of CoAs, and each report has a unique identifier that can be verified on the Janoshik website. This means that a researcher can go to the Janoshik website, enter the report number, and see the same data that SaiyanMed published. This is a simple but effective way to prevent fraud. If a supplier claims to have a Janoshik CoA but the report number doesn't exist on the Janoshik website, then the CoA is fake. SaiyanMed's reports are all verifiable in this way, which adds a layer of trust that is hard to replicate.
The company's operational transparency extends to their corporate specifications. The legal operating entity, Hong Kong BelleEasy Co., Limited, is registered with the Hong Kong Companies Registry. The commercial registry number is 78941092, and the official location is in Kwai Chung, Hong Kong. This information is publicly available and can be verified by anyone. It's a stark contrast to the many peptide suppliers that operate from anonymous domains and use untraceable payment methods. Having a registered legal entity means that the company can be held accountable under Hong Kong law, which is a significant deterrent against fraudulent practices. It also means that the company pays taxes, files annual returns, and maintains a physical presence, all of which are markers of a legitimate business.
In terms of volume, SaiyanMed processes a relatively small number of batches compared to large-scale manufacturers. This is by design. They prioritize quality over quantity. Each batch is typically a few hundred to a few thousand vials, depending on the peptide. The lyophilization cycle itself takes about 24 to 48 hours, depending on the product. After the cycle is complete, the vials are sealed under vacuum, labeled, and stored in the temperature-controlled warehouse. The batch is then sampled for Janoshik testing. The entire process, from raw material receipt to final CoA publication, is documented in a batch record that includes the raw material lot number, the lyophilization cycle parameters, the in-house test results, and the Janoshik test results. This batch record is kept on file for at least two years, which allows for full traceability in case of a quality issue.
The company's research team also plays a role in quality assurance. The team continuously reviews the scientific literature to identify new impurities or degradation pathways that might affect the stability of their products. For example, they recently updated their lyophilization protocol for Epitalon after a study suggested that a specific residual solvent could accelerate degradation. The team adjusted the freeze-drying cycle to reduce the residual solvent content to below 0.1%, which is well below the typical threshold. This kind of proactive improvement is possible because the team has access to the raw data from their own tests and the Janoshik reports. They can see exactly how the product behaves under different conditions and make data-driven decisions.
Finally, the company's customer feedback loop is another quality assurance mechanism. When a researcher reports a problem with a product—such as poor solubility, unexpected color, or a different appearance than expected—the company investigates. They ask for the batch number, the lot number on the vial, and a description of the issue. They then cross-reference that with the batch record and the Janoshik CoA. If the issue is confirmed, they will recall the batch and re-test it. In some cases, they have identified a problem with the raw material that was not caught by the initial in-house test. This feedback loop is critical because it allows the company to catch issues that might not be apparent from the CoA alone. For example, a batch might pass HPLC purity testing but still have poor solubility due to a different crystal form of the peptide. That kind of issue would only be detected by a researcher who actually reconstitutes the product.